Shanghai released a guideline on Monday to provide financial support for artificial intelligence (AI) projects, showing its ambition to build up an AI pilot zone for the nation amid the worldwide AI ... ( read original story ...)
China’s A-share market reforms have begun and investor interest is growing, so get ready to catch the wave
China has the world’s second-largest stock market but foreign ownership amounts to less than 3.5 per cent. Usually, when Hong Kong and foreign investors talk Chinese stocks, they’re not referring to ... ( read original story ...)
Chinese Financial Hub Unveils Guideline To Lift AI Academic Research In Next Three Years
The local government in eastern China’s Shanghai city has issued a guideline on Monday, seeking to transfer the global financial hub into a "hotbed" for artificial intelligence (AI) innovation. ( read original story ...)
Forget the Massacre of King’s Landing: The Battle for Shanghai Was Worse
the Battle of Shanghai took place under the eyes of numerous Westerners who could bear witness to the slaughter. “It was as though Verdun had happened on the Seine, in full view of a Right Bank ... ( read original story ...)
China’s regulator urges brokerages to monitor investors’ funding needs to trade on Nasdaq-style market
Investors hunt for gold ahead of debut of China’s Nasdaq-like technology board As of Monday, 108 technology firms had filed listing applications to the Shanghai Stock Exchange ... are borrowing money ... ( read original story ...)
SHANGHAI COMPOSITE : China stocks fall, yuan at four-month low as U.S. trade talks stall
SHANGHAI (Reuters) - China's main equity indexes finished lower ... adding that Beijing's options include support for stock markets and the yuan, as well as monetary policy measures and liquidity ... ( read original story ...)
Investors pile into Viva Biotech’s Hong Kong IPO as they are confident of the R&D services provider’s business model
The retail tranche of the Shanghai-based company’s HK$1.37 billion (US$176 million) IPO handily beat the 90.8 times subscription interest seen in vaccines developer Cansino Biologics’ offering in ... ( read original story ...)